- Approval Id
- c843ad031111ab96
- Drug Name
- HORGESIC TABLET 35MG/450MG
- Product Name
- HORGESIC TABLET 35MG/450MG
- Approval Number
- SIN16415P
- Approval Date
- 2022-01-07
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET
- Dosage
- <p><strong>Dosage and Administration</strong></p>
<table class="borderless-100">
<tbody>
<tr>
<td>Adult</td>
<td>:</td>
<td>Oral, 1 to 2 tablets three to four times daily up to a maximum of 8 tablets per day.</td>
</tr>
<tr>
<td>Children</td>
<td>:</td>
<td>Not recommended in children.</td>
</tr>
</tbody>
</table>
<p>Note: The information given here is limited. For further information consult your doctor or pharmacist.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications</strong><br>
Tension headache, occipital headaches associated with spasm of skeletal muscles in the region of the head and neck. Acute and traumatic conditions of the limbs and trunk: sprains, strains, whiplash injuries, acute torticollis, prolapsed intervertebral disc.</p>
- Contraindications
- <p><strong>Contraindications</strong><br>
Orphenadrine shows some anticholinergic activity and should not be used in patients with glaucoma, prostatic hypertrophy or obstruction at the bladder neck, or myasthenia gravis.</p>
- Atc Code
- M03BC51
- Atc Item Name
- orphenadrine, combinations
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
